Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas

Por Romani, Chiara, Comper, Fabrizio, Bandiera, Elisabetta, Ravaggi, Antonella, Bignotti, Eliana, Tassi, Renata A., Pecorelli, Sergio, Santin, Alessandro D.
Publicado em 2009

Identification of stably expressed reference small non‐coding RNAs for microRNA quantification in high‐grade serous ovarian carcinoma tissues

Por Bignotti, Eliana, Calza, Stefano, Tassi, Renata A., Zanotti, Laura, Bandiera, Elisabetta, Sartori, Enrico, Odicino, Franco E., Ravaggi, Antonella, Todeschini, Paola, Romani, Chiara
Publicado no J Cell Mol Med (2016)

Identification of Optimal Reference Genes for Gene Expression Normalization in a Wide Cohort of Endometrioid Endometrial Carcinoma Tissues

Por Romani, Chiara, Calza, Stefano, Todeschini, Paola, Tassi, Renata A., Zanotti, Laura, Bandiera, Elisabetta, Sartori, Enrico, Pecorelli, Sergio, Ravaggi, Antonella, Santin, Alessandro D., Bignotti, Eliana
Publicado no PLoS One (2014)

Serum human epididymis protein 4 (HE4) and Risk for Ovarian Malignancy Algorithm (ROMA) as new diagnostic and prognostic tools for epithelial ovarian cancer management

Por Bandiera, Elisabetta, Romani, Chiara, Specchia, Claudia, Zanotti, Laura, Galli, Claudio, Ruggeri, Giuseppina, Tognon, Germana, Bignotti, Eliana, Tassi, Renata A., Odicino, Franco, Caimi, Luigi, Sartori, Enrico, Santin, Alessandro D., Pecorelli, Sergio, Ravaggi, Antonella
Publicado em 2011

Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence

Por Tassi, Renata A, Calza, Stefano, Ravaggi, Antonella, Bignotti, Eliana, Odicino, Franco E, Tognon, Germana, Donzelli, Carla, Falchetti, Marcella, Rossi, Elisa, Todeschini, Paola, Romani, Chiara, Bandiera, Elisabetta, Zanotti, Laura, Pecorelli, Sergio, Santin, Alessandro D
Publicado em 2009

Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma

Por Bignotti, Eliana, Zanotti, Laura, Calza, Stefano, Falchetti, Marcella, Lonardi, Silvia, Ravaggi, Antonella, Romani, Chiara, Todeschini, Paola, Bandiera, Elisabetta, Tassi, Renata A, Facchetti, Fabio, Sartori, Enrico, Pecorelli, Sergio, Roque, Dana M, Santin, Alessandro D
Publicado em 2012

Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis

Por Bignotti, Eliana, Tassi, Renata A, Calza, Stefano, Ravaggi, Antonella, Rossi, Elisa, Donzelli, Carla, Todeschini, Paola, Romani, Chiara, Bandiera, Elisabetta, Zanotti, Laura, Carnazza, Mario, Quadraro, Francesco, Tognon, Germana, Sartori, Enrico, Pecorelli, Sergio, Roque, Dana M, Santin, Alessandro D
Publicado em 2013

A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer

Por Ratner, Elena S., Keane, Florence K., Lindner, Robert, Tassi, Renata A., Paranjape, Trupti, Glasgow, Michelle, Nallur, Sunitha, Deng, Yanhong, Lu, Lingeng, Steele, Linda, Sand, Sharon, Muller, Roman-Ulrich, Bignotti, Eliana, Bellone, Stefania, Boeke, Marta, Yao, Xiaopan, Pecorelli, Sergio, Ravaggi, Antonella, Katsaros, Dionyssios, Zelterman, Daniel, Cristea, Mihaela C., Yu, Herbert, Rutherford, Thomas J., Weitzel, Jeffrey N., Neuhausen, Susan L., Schwartz, Peter E., Slack, Frank J., Santin, Alessandro D., Weidhaas, Joanne B.
Publicado em 2011